Skip to main content
. 2021 Feb 25;13(5):950. doi: 10.3390/cancers13050950

Figure 11.

Figure 11

Kaplan–Meier estimates of disease-free survival (A) and overall survival (B) in patients at high-intermediate and high risk according to ESMO (n = 99), by molecular subgroup including β-catenin and ARID1A alterations.